MedTrace Logo

Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients

NCT03306914 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-01-28

No results posted yet for this study

Summary

In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.

Conditions

  • Anesthesia Morbidity

Interventions

OTHER

Albumin resuscitation

Albumin 5% is used as the intra-operative colloid

OTHER

Hydroxyethylstarch resuscitation

Hydroxyethyl starch 6% is used as the intra-operative colloid

DRUG

Albumin 5%

Infusion of Albumin 5% intra-operatively

DRUG

Hydroxyethylstarch 6%

Infusion of Hydroxyethylstarch 6% intra-operatively

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Ahmed Kareem · Kasr Al-Ainy Hospiral, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-15
Primary Completion
2019-02-01
Completion
2019-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03306914 on ClinicalTrials.gov